Clinical Trial Update: An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604 [Phase 1]

View source ↗

Summary

Phase 1 ADME study of AZD4604 and assessment of its absolute bioavailability has completed. The sponsor is AstraZeneca, with asthma listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD4604

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED